India has come up as a reliable healthcare destination with steadily expanding coverage and improving expertise.
13%
CAGR in in-patient market over 2015-20.
Top 3
healthcare markets in terms of incremental growth by 2020.
100%
FDI allowed under automatic route for greenfield projects.
US$2.3bn
Government investment over the period 2017-18 to 2019-20.
Ayushman Bharat
aims to provide annual healthcare coverage of nearly US$7,000 per family, benefiting more than 500 million vulnerable people.
US$32bn
diagnostics market expected by 2022, based on a CAGR of 20.4% from US$5bn in 2012.
28%
annual growth in India's healthcare technology startup space, where AI, IoT and data analytics are put to use for innovation solutions.
Medical Tourism
The Indian medical tourism industry, currently valued at around US$3bn, is expected to touch US$8bn by 2022.
US$21bn
expected valuation of India’s wellness and traditional healthcare industry by 2020, from the current US$10bn valuation.
US$4bn
worth od diagnostics industry in India is with the share of the organized sector being almost 25% in this segment (15% in labs and 10% in radiology).
US$13bn
worth of primary care industry with the share of the organized sector being practically negligible.
contact@ahpi.in
+91-11-23379651
info@mtaiindia.org
+91 124 4382629
ihpcia@ihpcia.org
+91-22-28741366
hsg@ima-india.org
+91-11-23370009, +91-9999116375
India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive and capital establishments
American drugmaker Merck operates a manufacturing plant in India.
French drugmaker Sanofi operates a manufacturing plant in Goa.
UK's GlaxoSmithKline operates R&D and manufacturing in India.
Singapore's 4CE Ventures has invested in Indian health tech startups.
India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive, and capital establishments